Founded in 2023 as one of Velocity Clinical Research’s first greenfield sites in the U.K., the experienced team at Velocity’s dedicated research site in Bristol conducts Phase 2-4 clinical trials across a broad variety of indications, including vaccines as well as medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. By developing strong working relationships with local communities and having close ties with networks of cooperating practices, Velocity’s Bristol staff provides fast, accurate patient enrollment support, even for diverse populations.
Our Bristol team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Bristol, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Now Enroling in Bristol
Velocity is enroling participants for clinical trials in Bristol for the following conditions:
- Asthma
- Chronic Back Pain
- Nonalcoholic Fatty Liver Disease (NAFLD)